Kingfa Q1 FY27 PAT doubles YoY to ₹80 Cr on margin expansion; MD, CFO reshuffled

Kingfa Science & Technology (India) reported standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations of ₹688.57 Cr, up 49.1% YoY from ₹461.93 Cr and up 19.0% QoQ from ₹578.47 Cr. Standalone net profit came in at ₹80.21 Cr, up 101.6% YoY from ₹39.79 Cr and up 35.6% QoQ from ₹59.15 Cr, with basic EPS at ₹59.19 versus ₹32.86 a year ago (+80.1%). PAT growing faster than revenue on both a YoY and QoQ basis is the core signal — this is a margin-expansion quarter, not just a volume story. The expansion sits on operating leverage rather than a one-off: cost of materials consumed rose 48.4% YoY (₹476.76 Cr vs ₹321.48 Cr), tracking revenue almost one-for-one, but employee benefits expense grew only 21.8% YoY (₹11.36 Cr vs ₹9.33 Cr) and other expenses rose 34.0% YoY (₹47.95 Cr vs ₹35.79 Cr) — both well below the topline growth rate. That gap lifted operating margin to roughly 16.1% from about 12.5% a year ago (+~360 bps) and net margin to roughly 11.6% from 8.55% (+~300 bps). No exceptional items appear in either period, so the growth is unadjusted and clean. Management has issued no formal quarterly guidance on record, and the filing carries no separate press-release commentary beyond the standard SEBI board-outcome disclosure, so there is no company framing to reconcile against. On the street side, no quarter-specific consensus estimate for Q1 FY27 could be found; the closest available reference is analyst commentary (Univest) projecting roughly 15-20% full-year FY27 PAT growth — this quarter's 101.6% YoY PAT print runs well ahead of that annual pace, which reads as a beat relative to the implied run-rate, though it is not a like-for-like quarterly estimate. The results were approved the same day the Board also recommended a final dividend of ₹20 per equity share (face value ₹10) for FY26, with a record date of September 21, 2026, and executed a sweeping leadership transition: Wang Dazhong takes over as Chairman & Managing Director from August 15, 2026 in place of Bo Jingen (who resigned), Xie Dongming returns as CFO in place of Chen Xiaoqiong, Sethuraman Shanmugasundaram becomes Whole-time Director/COO, and new CTO (He Liuwei) and CMO (Saravanan Balasundaram) appointments were also made. Going into Q2 FY27, the print sets up two things to track together: whether the ~49% revenue growth and ~360 bps of operating-margin expansion can hold as raw-material costs move, and whether the concurrent change at Chairman/MD, CFO and COO level introduces any near-term execution friction even as the underlying numbers this quarter were strong.